As part of an online conference hosted by the Alzheimer’s Foundation of America, Associate Professor of Medicine at New York University’s (NYU) Long Island…
Despite the absence of disease-modifying treatments, the dementia rate in developed Western countries has actually declined in recent years. In fact, one study showed…
Apathy is an extremely common symptom of Alzheimer’s. It impairs patients’ ability to socialize and maintain routines, activities that are central to preserving their…
Diagnosing degenerative brain diseases early and accurately is a major challenge, and it can take years before a patient receives an accurate diagnosis. But…
You may have read about it in the New York Post: “Scientists pinpoint personality traits that increase risk of Alzheimer’s.” A recent study published in…
Georg Meisl, a research associate at Yusuf Hamied Department of Chemistry, University of Cambridge shares insight into new research that sheds light on just…
Following the approval of the Alzheimer’s drug Aduhelm — and the litany of controversy surrounding it — one question that’s top of mind for…
This article is part of the series Diversity & Dementia, produced by Being Patient with support provided by Eisai. Image courtesy of Brian Van Buren. Image:…
In the 1980s, when Cindy Weinstein was a graduate student of English, developing her expertise in language and literature, her father Jerry, now deceased,…
Anthony Copeland-Parker and his partner Catherine Elizabeth Popp have long had a passion for traveling and endurance running. And they weren’t about to let…
Almost 60 percent of people with Alzheimer’s also show signs of seizure-like brain activity. In total, more than one fifth of people with Alzheimer’s…
Analyzing large databases of human data, scientists identified a “water pill” called bumetanide, which reduced the risk of developing Alzheimer’s for people with a…
Alzheimer’s can often be a long, drawn-out illness, and for Patti Davis, this long goodbye was also a blessing. Looking back on her late…
Time is of the essence when it comes to Alzheimer’s — early diagnosis provides more time to intervene and slow its progress. Current technology…
This panel discussion is part of Being Patient’s Diversity & Dementia series, produced with support provided by Eisai. Black and Hispanic people are at a…